JCI - Citations to Increased Plasminogen Activator (Urokinase) in Tissue Culture After Fibrin Deposition

Citations to this article

Increased Plasminogen Activator (Urokinase) in Tissue Culture After Fibrin Deposition

Maria B. Bernik

Maria B. Bernik

Published April 1, 1973
Citation Information: J Clin Invest. 1973;52(4):823-834. https://doi.org/10.1172/JCI107246.

View: Text | PDF

Research Article

Total citations by year

Year:	2019	2017	2016	2011	2006	2001	2000	1999	1997	1996	1995	1992	1991	1990	1989	1988	1987	1986	1985	1984	1983	1982	1981	1979	1977	1976	1974	Total
Citations:	7	3	1	1	1	3	1	2	2	1	1	4	1	3	4	5	5	10	7	5	5	4	3	2	2	2	2	87

Citation information

Citations to this article (87)

Title and authors	Publication	Year
Therapeutic Enzymes: Function and Clinical Implications N Labrou		2019
Therapeutic Enzymes: Function and Clinical Implications N Labrou		2019
Therapeutic Enzymes: Function and Clinical Implications N Labrou		2019
Therapeutic Enzymes: Function and Clinical Implications N Labrou		2019
Therapeutic Enzymes: Function and Clinical Implications N Labrou		2019
Therapeutic Enzymes: Function and Clinical Implications N Labrou		2019
Therapeutic Enzymes: Function and Clinical Implications N Labrou		2019
Physiology and pathophysiology of the plasminogen system in the kidney P Svenningsen, GR Hinrichs, R Zachar, R Ydegaard, BL Jensen	Pflügers Archiv - European Journal of Physiology	2017
Bioresources and Bioprocess in Biotechnology S Sugathan, NS Pradeep, S Abdulhameed	Bioresources and Bioprocess in Biotechnology	2017
Translational initiatives in thrombolytic therapy ME Klegerman	Frontiers of Medicine	2017
Trauma Induced Coagulopathy E Gonzalez, HB Moore, EE Moore		2016
Annual Reports in Medicinal Chemistry JJ Liu, TW Lee	Annual Reports in Medicinal Chemistry Volume 46	2011
Soluble expression of a strong thrombolytic pro-urokinase mutant in Escherichia coli J Lin, X Yang, R Deng, B Yu, H Lai, W Sun, W Wu	Protein Expression and Purification	2006
Thrombolytic therapy for ischemic stroke—A review. Part I—Intravenous thrombolysis PD Schellinger, JB Fiebach, A Mohr, PA Ringleb, O Jansen, W Hacke	Critical Care Medicine	2001
Plasma thrombin–antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis Y Inaba, M Ichikawa, A Inoue, M Itoh, M Kyogashima, Y Sekiguchi, S Nakamura, A Komiyama, CS Koh	Journal of the Neurological Sciences	2001
Fibrinolytics and Antifibrinolytics F Bachmann		2001
Platelets JN George	The Lancet	2000
Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction M Moser, C Bode	Expert Opinion on Investigational Drugs	1999
Suppression of Experimental Autoimmune Encephalomyelitis by Dermatan Sulfate Y Inaba, M Ichikawa, CS Koh, A Inoue, M Itoh, M Kyogashima, A Komiyama	Cellular Immunology	1999
Fibrin deposition in the central nervous system correlates with the degree of Theiler's murine encephalomyelitis virus-induced demyelinating disease A Inoue, CS Koh, M Yamazaki, N Yanagisawa, Y Ishihara, BS Kim	Journal of Neuroimmunology	1997
Thrombolytic therapy of acute myocardial infarction with saruplase, a single-chain urokinase-type plasminogen activator (scu-PA) from recombinant bacteria U Tebbe, WA Günzler, GR Hopkins, T Grymbowski, H Barth	Fibrinolysis and Proteolysis	1997
Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats A Inoue, CS Koh, K Shimada, N Yanagisawa, K Yoshimura	Journal of Neuroimmunology	1996
A double-blind multicenter comparison of the efficacy and safety ofsaruplase andurokinase in thetreatment ofacutemyocardialinfarction: Report of the SUTAMI study group R Michels, H Hoffmann, J Windeler, H Barth, G Hopkins	Journal of Thrombosis and Thrombolysis	1995
Proteases MA Phillips, RJ Fletterick	Current Opinion in Structural Biology	1992
Concordance and localization of maximal vascular permeability change and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis CS Koh, J Gausas, PY Paterson	Journal of Neuroimmunology	1992
Fibrinolytic enzymes in ascites during experimental acute pancreatitis in rats Y Etoh, H Sumi, H Tsushima, M Maruyama, H Mihara	International Journal of Gastrointestinal Cancer	1992
High expression vectors for the production of recombinant single-chain urinary plasminogen activator from Escherichia coli R Brigelius-Floh, G Steffens, W Strassburger, L Floh	Applied Microbiology and Biotechnology	1992
Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin GA de Munk, E Groeneveld, DC Rijken	Journal of Clinical Investigation	1991
Fibrinolytic properties of single chain urokinase-type plasminogen activator (Pro-urokinase) GA Munk, DC Rijken	Fibrinolysis	1990
Neurovascular fibrinolytic activity in normal Lewis rats and rats with cell-transferred experimental allergic encephalomyelitis CS Koh, HC Kwaan, PY Paterson	Journal of Neuroimmunology	1990
Pharmacologic Review of Thrombolytic Agents EM Kline	Critical Care Nursing Clinics of North America	1990
Additive fibrinolysis by recombinant tissue-type plasminogen activator (r-t-PA) and recombinant single-chain urokinase type plasminogen activator (r-scu-PA) in rabbit pulmonary thrombosis J Schneider, E Friderichs, WA Günzler, L Flohé	Thrombosis Research	1989
The sequential, complementary and synergistic activation of fibrin-bound plasminogen by tissue plasminogen activator and pro-urokinase V Gurewich	Fibrinolysis	1989
Niere und Blutgerinnung J Schrader		1989
Coronary thrombolysis AG Wasserman, AM Ross	Current Problems in Cardiology	1989
Plasminogen Activation: Biochemistry, Physiology, and Therapeutics TC Wun	Critical Reviews in Biotechnology	1988
Great variation in the response of tissue plasminogen activator activity, plasminogen activator inhibition and plasmin inhibition to endotoxin, aspirin and endotoxin after administration of aspirin A Smokovitis, N Kokolis, T Ploumis	Thrombosis Research	1988
Fibrin-specific thrombolytic therapy D Collen	Thrombosis Research	1988
Distribution of plasminogen activators in human kidney and male genital organs using a highly sensitive enzyme immunoassay Y Hasui, J Suzumiya, A Sumiyoshi, S Hashida, E Ishikawa	Thrombosis Research	1988
Randomized, double-blinded multicenter study. Comparison of intracoronary single-chain urokinase-type plasminogen activator, pro-urokinase (GE-0943), and intracoronary urokinase in patients with acute myocardial infarction H Kambara, C Kawai, N Kajiwara, H Niitani, S Sasayama, K Kanmatsuse, K Kodama, H Sato, M Nobuyoshi, M Nakashima	Circulation	1988
Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy D Collen	Journal of Cellular Biochemistry	1987
Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator JC KIRCHHEIMER, I RESCH, G CHRIST, J WOJTA, BR BINDER	European Journal of Biochemistry	1987
Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor CS Koh, PY Paterson	Cellular Immunology	1987
Identification of two types of protein immunochemically related to urinary urokinase occurring in human plasma DJ Binnema, G Dooijewaard, JJ Iersel	Biochemical and Biophysical Research Communications	1987
Thrombolytische Therapie des akuten Herzinfarkts DP de Bono, ML Brochier, PG Hugenholtz, W Kübler, M Verstraete		1987
Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator HR Lijnen, BV Hoef, D Collen	Biochimica et Biophysica Acta (BBA) - General Subjects	1986
Quantitation of urokinase antigen in plasma and culture media by use of an elisa DJ Binnema, JJ Iersel, G Dooijewaard	Thrombosis Research	1986
Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell culture G Wijngaards, DC Rijken, AL Wezel, E Groeneveld, CA der Velden	Thrombosis Research	1986
Analytic Review: Thrombolytic Therapy in Acute Myocardial Infarction PL Zwerner, JM Gore	Journal of Intensive Care Medicine	1986
Purification and characterization of recombinant single-chain urokinase produced in Escherichia coli ME Winkler, M Blaber	Biochemistry	1986
Facts and Hopes in Thrombolysis in Acute Myocardial Infarction S Effert, R von Essen, PG Hugenholtz, R Uebis, M Verstraete		1986
Activation of plasminogen by pro-urokinase. I. Mechanism HR Lijnen, C Zamarron, M Blaber, ME Winkler, D Collen	The Journal of biological chemistry	1986
Activation of plasminogen by pro-urokinase. II. Kinetics D Collen, C Zamarron, HR Lijnen, M Hoylaerts	The Journal of biological chemistry	1986
Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures DC Stump, HR Lijnen, D Collen	The Journal of biological chemistry	1986
Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex DC Stump, M Thienpont, D Collen	The Journal of biological chemistry	1986
Les activateurs du plasminogène: aspects généraux et développements récents M Reboud-Ravaux	Biochimie	1985
Purification and Characterization of Recombinant Urokinase from Escherichia coli ME Winkler, M Blaber, GL Bennett, W Holmes, GA Vehar	Bio/Technology	1985
Characterization of the high-affinity interaction between human plasminogen and pro-urokinase HR LIJNEN, C ZAMARRON, D COLLEN	European Journal of Biochemistry	1985
Kinetic analysis of plasminogen activation by purified plasma kallikren M Jörg, BR Binder	Thrombosis Research	1985
Coronary thrombolysis in dogs with intravenously administered human pro-urokinase D Collen, D Stump, F van de Werf, IK Jang, M Nobuhara, HR Lijnen	Circulation	1985
Primary structure of single-chain pro-urokinase S Kasai, H Arimura, M Nishida, T Suyama	The Journal of biological chemistry	1985
Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin S Kasai, H Arimura, M Nishida, T Suyama	The Journal of biological chemistry	1985
Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species V Gurewich, R Pannell, S Louie, P Kelley, RL Suddith, R Greenlee	Journal of Clinical Investigation	1984
The fibrinolytic system in man AP Reiner, WR Bell	Critical Reviews in Oncology/Hematology	1984
Biochemical changes in endothelial cell monolayers induced by fibrin deposition in vitro RR Schleef, CR Birdwell	Arteriosclerosis (Dallas, Tex.)	1984
New approaches to thrombolytic therapy D Collen, HR Lijnen	Arteriosclerosis (Dallas, Tex.)	1984
Eukaryotic Cell Cultures RT Acton, JD Lynn		1984
Plasminogen activator in normal and tumor-bearing mice MR Bruesch, GL Johnson, CS Palackdharry, MJ Weber, PL Carl	International Journal of Cancer	1983
Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin DL Eaton, JB Baker	The Journal of Cell Biology	1983
New Comprehensive Biochemistry S Yamamoto	New Comprehensive Biochemistry	1983
The Physiology of Hemostasis D Ogston		1983
Regulation of extracellular plasminogen activator by human fibroblasts. The role of protease nexin RW Scott, DL Eaton, N Duran, JB Baker	The Journal of biological chemistry	1983
The Primary Structure of High Molecular Mass Urokinase from Human Urine. The Complete Amino Arid Sequence of the A Chain WA GÜNZLER, GJ STEFFENS, F ÖTTING, SM KIM, E FRANKUS, L FLOHÉ	Hoppe-Seyler´s Zeitschrift für physiologische Chemie	1982
Analysis of procoagulant activity of intact cells from tissue culture SG Gordon, LC Gilbert, BJ Lewis	Thrombosis Research	1982
Effect of thrombin on glycosaminoglycans in fibroblast cultures PD Kittlick, G Neupert	Experimental Pathology	1982
A proenzyme form of human urokinase TC Wun, L Ossowski, E Reich	The Journal of biological chemistry	1982
ROLE OF PLATELETS IN THE DEVELOPMENT OF ATHEROSCLEROTIC DISEASE AND POSSIBLE INTERFERENCE WITH PLATELET INHIBITOR DRUGS V Fuster	Scandinavian Journal of Haematology	1981
Studies on the release of plasminogen activator from the isolated rat lung by serine proteinases HP Klöcking, C Jablonowski, F Markwardt	Thrombosis Research	1981
Subcellular Biochemistry DB Roodyn	Subcellular Biochemistry	1981
The demonstration of urokinase antigen in whole blood M Shakespeare, P Wolf	Thrombosis Research	1979
Concanavalin a stimulation of plasminogen activator production in pig kidney cells in culture E Mochan	Biochimica et Biophysica Acta (BBA) - General Subjects	1979
Biosynthesis of Plasminogen Activator by Tissue Culture Technique GH Barlow, A Rueter, I Tribby	Vascular and endovascular surgery	1977
Biomedical Applications of Immobilized Enzymes and Proteins TM Chang		1977
Insoluble “fibrin” in human aortic intima EB Smith, KM Alexander, IB Massie	Atherosclerosis	1976
Inflammatory sequences in acute pulmonary radiation injury DO Slauson, FF Hahn, SA Benjamin, TL Chiffelle, RK Jones	The American Journal of Pathology	1976
Properties of plasminogen activators formed by neoplastic human cell cultures DB Rifkin, JN Loeb, G Moore, E Reich	Journal of Experimental Medicine	1974
Proteinase Inhibitors H Fritz, H Tschesche, LJ Greene, E Truscheit		1974

Advertisement